Biochemical assays on plasminogen activators and hormones from kidney sources by Barlow, Grant H. et al.
N89-20287 
BIOCHEMICAL CISSAYS ON PLASMINOGEN A C T I V A T O R S  
AND 
HORHONES FROH KIDNEY SOURCES 
G R A N T  H BAHLOW, M A R I A N  L LEWIS, AND GENNIS R M O R R I S O N  
B i o p r D c e s s i n j  R e s e a r c h  C e n t e r ,  U n i v e r s i t y  o f  Texas H e a l t h  
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S c i e n c e  D i v i s i o n ,  Hcritston, f ind NASA-Johnson Space C e n t e r ,  H o u s t o n  
E v e r  s i n c e  W i l l i a m s  ( 1 )  f i r s t  d e s c r i b e d  t h e  p l a s m i n o g e n  a c t i v a t o r  
f r o m  human u r i n e  and S o b e l  ( 2 )  named i t  u r o k i n a s e  (UIO and t h e  v a s c u l a r  
a c t i v a t o r  was d e s c r i b e d  b y  A o k i  ( 3 )  t h e  a c t i v a t o r  s y s t e m  i n  man ha5 become 
more comp lex .  What a t  f i r s t  a p p e a r e d  t o  b e  s i n g l e  w e l l  d e f i n e d  p r o t e i n s  h a v e  
now been  shown t o  e x i s t  i n  m u l t i p l e  m o l e c u l a r  f o r m s .  UK c a n  e x i s t  a s  a 
s i n g l e  or t w o  c h a i n  m o l e c u l e  ( 4 )  and a5 a f u l l y  a c t i v e  d e g r a d e d  t w o  c h a i n  
f o r m  ( 5 ) ,  O T  a d e g r a d e d  s i n g l e  c h a i n  f o r m  ( b ) .  V a s c u l a r  a c t i v a t o r ,  w h i c h  i s  
now n o r e  w i d e l y  known a s  t i s s u e  p l a s m i n o g e n  a c t i v a t o r  ( t - P A ) ,  c a n  a l s o  e x i s t  
as  a s i n g l e  or t w o  c h a i n  m o l e c u l e  (7) and h a s  been  r e p o r t e d  t o  a l s o  h a v e  a 
d e g r a d e d  f o r m  (8). I n  a n y  n o r m a l  s y s t e m  t h e  p r e s e n c e  o f  many d i f f e r e n t  
m o l e c u l a r  fo rms i s  h i g h l y  p o s s i b l e  and based  on t h e  p o t e n t i a l  f o r  d i f f e r e n t  
r e s p o n s e s  i n  d i f f e r e n t  a s s a y s  c a n  l e a d  t o  a v e r y  comp lex  p r o b l e m  w i t h  
i n t e r p r e t a t i o n  ( 9 ) .  
D e t e r m i n a t i o n  o f  a c t i v i t y  l e v e l s  c a n  b e  ft!;.ther c o m p l i c a t e d  b y  
i n h i b i t o r s  t o  t h e  a c t i v a t o r  a s  w e l l  a5 t c ,  p l a s m i n ,  t h e  end p r o d u c t  o f  t h e  
e n z r n a t i c  a c t i v i t y  o f  t h e  a c t i v a t o r s .  The use o f  a m i d o l y t i c  and e s t e r o l y t i c  
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assays that %t?a5ure the enzyme activity directly can give a very  different 
response chan those assays which are of the indirect nature requiring t h e  
measurement of the enzyme plasmin, the results of t h e  activation of plas- 
minogen o y  the activator. 
These investigations were established for t h e  purpose of analyzing 
the conditioned media from human embryonic kidney cell subpopulations 
separated i n  space b y  electrophoresis. This data is based on t h e  experiments 
performed on STS-8 on the Continuous Flow Electrophoresis System ( C F E S ) ,  
developed b y  McDonnell-Douglas flstronautics Co. The primary biological 
activity that was analyzed wa5 piasminogen activator activity, but some 
assays for erythropoeitin and human granulocyte colony stimulating activity 
were also performed. 
The cell preparation prior t o  separation and t h e  subsequent 
culturing of t h e  sub-fractions were not part o f  these investigations and 
were accomplished at the Johnson Space Center. 
Erakkman ( 1 0 )  and modified by the addition o f  plasminogen ( 1 1 )  was adapted 
a s  follows. In 15 X 100 m m  disposable petri plates t h e  following materials 
were added: 10 m 1  of 7.5 mg/rl plasminogen free b o v i n e  fibrinogen (Miles 
Laboratories, Naperville, IL) in a 0.1 nol/l TRIS-HC1 pH 8.0 buffer, 75 mg 
of human lys-plasminogen (American Diagnostica), and 4 IU plasminogen f r e e  
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h u v i n e  t h r o n b i n  ! i l i l e s  L a b ' o r a t o r i e s i  i n  a 0.02 m o l / l  CaCl2 + 0 .15 m o i l 1  NaCl 
s o l u t i o n .  To t h e  c l o t s  
L'Jur s e r i a l  t w o - f o l d  d i  
a t  a m b i e n t  t e n p e r a t u r e ,  
dyne  G e n e r a i  i l i n n  A r b o r  
2 0  u l  vo lumes  o t  t h e  c o n d i t i c n e d  medium sample a t  
u t i o n s  were a p p l i e d  t o  each p l a t e .  C I f t e r  13  h o u r s  
t h e  l y s i s  z o n e  d i a m e t e r s  were r e a d  u s i n g  a T r a n s i -  
M I )  c a l i b r a t i n g  v i e w e r  (mode i  274:). 
- - - - - - - - - - - - -_______-- - - - - - - -  M I C R O - C L U T  L ' i ' : I S  CiSSU'?' (MCLAI: T h i s  assay ,  d e v e l o p e d  i n  o u r  l a b o r a t o r y  
was d e s c r i b e d  b y  L e w i s  E L  s i ,  ( l ? !  and u t i l i z e s  96 w e l l  f l a t  b o t t o m  m i c r o -  
w e l l  p l a t e s .  The r e a c t i o n  m i x t u r e  i n  t h e  w e l l s  c o n s i s t e d  o f  a f i b r i n o g e n  
r o l u t i o n  c o n t a i n i n g  p l a s m i n o g e n ,  t h r o m b i n ,  and t h e  c o n d i t i o n e d  medium s a r p l e  
o f  PA s t a n d a r d .  The o p t i c a l  d e n s i t y  o f  t h e  c l o t s  i n  each  w e l l  was a r b i -  
t r a r i l y  m o n i t o r e d  a t  4 0 5  nm a t  5 m i n u t e  i n t e r v a l s  u s i n g  an E I A  a u t o m a t e d  
m i c r o p l a t e  r e a d e r  i B i o - T e k  I n s t r u m e n t s ,  W i n o e s k i ,  V T ,  model  EL310) .  The 
r e a d e r  was c o n n e c t e d  v i a  a s e r i a l  i n t e r f a c e  t o  an A p p l e  I I e  c o m p u t e r .  The 
c o m p u t e r  r e c e i v e d  t h e  d a t a  and d e t e r m i n e d  t h e  t i m e  a t  w h i c h  t h e  c l o t s  w e r e  
h a l f  l y s e d ,  t h e  a s s a y  e n d p o i n t ,  b y  u s e  o f  s o f t w a r e  d e v e l o p e d  on t h e  A p p l e  
I I e  f o r  t h i s  a s s a y .  As w i t h  t h e  FPL assay, t h e  a c t i v i t y  f o r  each  samp le  was 
d e r i v e d  by c o m p a r i s o n  t o  t h e  IHP-UK. 
B M 1 p p l v l 1 C - ~ S S 4 1 _ 1 S ~ ~ ~ ~ ~ ~ :  The ami d o l  y t i c  assay  u s i n g  t 'he s y n t h e t i c  
s u b s t r a t e  Py ro -G lu -G ly -A rg -pNA ( 5 2 4 4 4 ,  K a b i V i t r u m ,  Sweden) was e s s e n t i a l l y  
t h a t  d e s c r i b e d  b y  C l a e s o n  21 .  ( 1 3 ) .  F o r  a c t i v a t i o n  o f  l a t e n t  P A  i n  t h e  
c o n d i t i o n e d  medium, s a m p l e s  were  i n c u b a t e d  f o r  30 m i n u t e s  a t  37OC w i t h  human 
p l a s m i n  ( A m e r i c a n  D i a g n o s t i c a )  a t  a f i n a l  c o n c e n t r a t i o n  o f  2 .3  u g / a l  o f  
samp le  vo lume.  A c t i v a t i o n  was s t o p p e d  b y  t h e  a d d i t i o n  o f  a p r o t i n i n  
( T r a s y l o l ,  FBA P h a r m a c e u t i c a l s ,  New Y o r k ,  NY) a t  10 I ( I U / m l  i n  a 
TRIS-NaCl-HC1 b u f f e r  a t  pH 8.8. S-2444  wa5 t h e n  added t o  t h i s  s o l u t i o n  i n  
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t h e  w e l l s  o f  r i c r o t i t e r  p l a t e s  and t h e  p l a t e s  were i n c u b a t e d  an a d d i t i o n a l  4 
h o u r s  a t  37OC. 
( C h a r l e s t o n ,  SC) model  LB130 m i c r o p l a t e  r e a d e r .  The d i r e c t  assay  p l a t e s  
( w i t h o u t  p l a 5 m i n  i n c u b a t i o n )  were h a n d l e d  i n  t h e  same manner e x c e p t  t h a t  
i n s t e a d  o f  a d d i t i o n  o f  p l a s m i n ,  an e q u i v a l e n t  vo lume o f  t h e  TRIS-NaC1-HC1 
b u f f e r  Has added t o  samp les .  
The a b s o r p t a n c e  was r e a d  a t  405 nm u s i n g  a L i t t o n  E i o n e t i c s  
I l s s u E - P I e S M l N p c E N _ B ~ ~ l A ~ e I p ~ - ~ I ~ ~ e ~ :  The m a t e r i a l s  and me thods  f o r  t h e  
t -PA a s s a y  were  c o n t a i n e d  w i t h i n  t h e  IMUBIND t-PA ELISA k i t  f r o m  A m e r i c a n  
D i a g n o s t i c a  ( 1 4 ) .  The a s s a y  was m o d i f i e d  u s i n g  medium c o n t a i n i n g  human 
serum albumen a s  a d i l u e n t .  The f l a t  b o t t o m  m i c r o w e l l  p l a t e s  ( I m m u l o n  2 ,  
D y n a t e c h  L a b o r a t o r i e s ,  A l e x a n d r i a ,  V A )  p l a t e s  were r e a d  a t  490 nm on t h e  
EL310 a u t o r e a d e r .  
PIfiSfllAN-lNliBiIQflS: To d e t e r m i n e  p r e s e n c e  o f  p l a s m i n  i n h i b i t o r s  i n  t h e  
c o n d i t i o n e d  medium, s a m p l e s  were i n c u b a t e d  w i t h  a known e x c e s s  o f  human 
l y s - p l a s m i n .  R e s i d u a l  p l a s m i n  a c t i v i t y  n a s  measured b y  t h e  c h r o m o g e n i c  
s u b s t r a t e  H-D-Val-Leu-Lys-pNA (S-2252, K a b i V i t r u m ,  Sweden) a t  405 nm ( 1 5 )  
u s i n g  t h e  LB130 r e a d e r .  R e s u l t s  a r e  e x p r e s s e d  a s  p e r c e n t  r e d u c t i o n  i n  
p l a s m i n  a c t i v i t y  i n  t h e  c o n d i t i o n e d  medium s a m p l e s  f r o m  t h e  c u l t u r e d  c e l l s  
compared t o  t h e  u n c o n d i t i o n e d  medium. 
SoDlun BoDECVL S U L E e I E  PPlvecevMlPE ELECIBeeHBBESIs, tsus PBEEl, BN!! 
___------- ZYHOGRAPHY: SDSPAGE e l e c t r o p h o r e s i s  t o  d e t e r m i n e  t h e  m o l e c u l a r  n e i g h t  o f  
t h e  enzyme was p e r f o r m e d  a s  d e s c r i b e d  b y  L a e n n l i  ( 1 6 ) .  The r e s u l t a n t  g e l s  
were  a n a l y z e d  f o r  f u n c t i o n a l  a c t i v i t y  b y  d e v e l o p m e n t  o f  a z y w o g r a p h  b y  t h e  
me thod  o f  T i s s o t  ( 1 7 )  i n v o l v i n g  a f i b r i n  o v e r l a y .  
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E#yIYcQPPIEI/l: T h i s  assay was pe r fo rmed  u s i n g  a c o m m e r c i a l l y  a v a i l a b l e  
ELISA k i t  purchased f r o m  JCL C l i n i c a l  Research Corp. ( K n o x v i l l e ,  Tenn. ) .  The 
a n a l y s e s  were pe r fo rmed  as d e s c r i b e d  i n  t h e  methods b r o c h u r e  s u p p l i e d  w i t h  
t h e  k i t .  
HUUfiN Gf?fi&JICJCYIE W2QyY sIjdY'flIi4c iACIAvJI_V: T h i s  assay was pe r fo rmed  
u s i n g  mouse marrow c e l l s  a t  a c o n c e n t r a t i o n  o f  75000 c e l l s / e l .  as d e s c r i b e d  
by  D i p e r s i o  e t  a1 ( 1 8 ) .  
RESULTS 
F i g u r e  1 shows t h e  r e s u l t s  on t h e  c o n d i t i o n e d  media f r o m  t h e  
s u b p o p u l a t i o n s  by  two assay f o r  p lasminogen a c t i v a t o r  a c t i v i t y ,  t h e  f i b r i n  
p l a t e  l y s i s  assay and t h e  d i r e c t  assay u s i n g  t h e  chromogenic  s u b s t r a t e  
5-2444 .  As can be seen t h e r e  i s  a l a r g e  d i s c r e p a n c y  between t h e  a c t i v i t y  
l e v e l s  as measured by t h e s e  two d i f f e r e n t  assays. 
F i g u r e  2 shows t h e  r e s u l t s  compar ing  t h e  S-2444 d i r e c t  w i t h  t h e  
S-2444 a c t i v a t e d .  These r e s u l t s  show t h a t  'much o f  t h e  samples a r e  in t h e  
s i n g l e  c h a i n  zymogen f o r m  and when a c t i v a t e d  w i t h  p l a s m i n  t o  t h e  two c h a i n  
f o r m  shon a s u b s t a n t i a l  i n c r e a s e  i n  a c t i v i t y .  
F i g u r e  3A shons a compar ison o f  t h e  m i c r o  c l o t  l y s i s  assay w i t h  
t h e  f i b r i n  p l a t e  l y s i s  assay. As can be seen t h e r e  i s  good c o r r e l a t i o n  
between t h e  two assays excep t  i n  t h e  s u b p o p u l a t i o n  r e g i o n  f r o m . f r a c t i o n  9 
t h r u  15. I n  F i g u r e  3B t h e s e  sane f r a c t i o n s  were ana lyzed  f o r  t h e  p resence  o f  
p l a s m i n  i n h i b i t o r  and t h e  f r a c t i o n s  i n  t h e  range  9-15 shon s i g n i f i c a n t  
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a n t i - p l a s m i n  a c t i v i t y .  Thus t h e  p r e s e n c e  o f  a n t i  p l a s m i n  i n  t h e s e  f r a c t i o n s  
appear  t o  be t h e  c a u s e  f o r  t h e  d i s c r e p a n c y  be tween  t h e  t w o  d i f f e r e n t  a s s a y s .  
The FPL assay a p p e a r s  t o  b e  i n d e p e n d e n t  o f  t h e  p r e s e n c e  o f  i n h i b i t o r  w h i l e  
t h e  H C L A  assay  i s  depended on t h e  p r e s e n c e  o f  such  an i n h i b i t o r .  
F i g u r e  4 shows t h e  e n t i r e  s e t  o f  d a t a  on t h e  s u b f r a c t i o n s  b y  t h e  
d i f f e r e n t  a s s a y s .  The r e s s l t s  o b t a i n e d  a r e  v e r y  d e p e n d e n t  on t h e  a s s a y  t h a t  
i s  p e r f o r m e d  and p o i n t s  o u t  d r a m a t i c a l l y  t h e  need t o  u s e  a b a t t e r y  o f  a s s a y s  
t o  d e f i n e  t h e  p l a s m i n o g e n  a c t i v a t o r  p r o f i l e  o f  a samp le  f r o m  t h e  c o n d i t i o n e d  
med ia  o i  c e l l s  i n  c u l t u r e .  
F i g u r e  5A shows a t y p i c a l  f i b r i n o g r a m  on s e l e c t e d  s u b p o p u l a t i o n  
s a m p l e s .  These f r a c t i o n s  a l l  show t h e  p r e s e n c e  o f  o n l y  s p e c i e s  a t  54 ,000  
d a l t o n s ,  b u t  do n o t  d i s t i n g u i s h  b e t w e e n  s i n g l e  and two c h a i n  f o r m s .  F i g u r e s  
5B and 5 C  show t h e  same g e l  on f i b r i n o g r a m s  i n  w h i c h  t h e  f i b r i n  o v e r l a y  h a s  
been  t r e a t e d  w i t h  s p e c i f i c  a n t i b o d y  f o r  u-PA t o  t - P A  and a l l o w s  one t o  
d e t e r m i n e  t h e  s p e c i e s  p r e s e n t  
W h i l e  t h e  m a j o r i t y  o f  t h e  a n a l y s e s  were  t o  s t u d y  t h e  d i s t r i b u t i o n  
o f  p l a s m i n o g e n  a c t i v a t o r ( s 1 ,  we d i d  p e r f o r m  a s s a y s  f o r  t w o  o t h e r  b i o l o g i c a l  
a c t i v i t i e s  a s s o c i a t e d  w i t h  e m b r y o n i c  k i d n e y  c e l l s  i n  c u l t u r e .  The ELISA 
a s s a y  f o r  e r y t h r o p o e i t i n  showed a r e a s  o f  p o s i t i v e  r e s p o n s e  b u t  t h e y  were a t  
a v e r y  l o w  l e v e l .  However,  on t r i p l i c a t e  d e t e r m i n a t i o n s  on t h e  g r o w t h  medium 
f r o m  r u n  4 t h e r e  were c o n s i s t e n t  i n d i c a t i o n s  o f  a p o s i t i v e  r e s p o n s e  i n  some 
s u b p o p u l a t i o n s ,  t h e s e  p o s i t i v e  s u b p o p u l a t i o n s  showed l e v e l s  o f  a b o u t  10 
m i l l i - i m m u n o l o g i c a l  u n i t s  p e r  m i l l i l i t e r  when compared w i t h  t h e  s t a n d a r d .  
The a s s a y  k i t  a s  d e t e r m i n e d  b y  our  s t a n d a r d  c u r v e  i s  i n s e n s i t i v e  t o  l e v e l s  
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b e i o w  t h e  li? m i l l i u n i t s  we d e t e c t e d .  The mouse marrow assay  f o r  g r a n u l o c y t e  
c o l o n y  s t i m u l a t i n g  a c t i v i t y  was r u n  on t h e  g r o w t h  m e d i a  f r o m  b o t h  r u n s  3 and 
4 and i n  b o t h  c a s e s  t h e  r e s u l t s  were n e g a t i v e .  
DISCUSSION 
The m a j o r  c o n c l u s i o n  t h a t  can  b e  r e a c h e d  b y  t h i s  work 1 s  t h a t  a 
b a t t e r y  o f  a s s a y s  a r e  r e q u i r e d  t o  c o m p l e t e l y  d e f i n e  t h e  p l a s m i n o g e n  a c t i v -  
a t o r  p r o f i l e  o f  a c o n d i t i o n e d  med ia  f r o m  c e l l  c u l t u r e .  Each t y p e  o f  a s s a y  
measures  d i f f e r e n t  p a r t s  o f  t h e  m i x t u r e  and a r e  i n f l u e n c e d  b y  d i f f e r e n t  
p a r a m e t e r s .  T a b l e  1 e x p r e s s e s  t h e  f u n c t i o n a l  r o l e  o f  e a c h  a s s a y  and g i v e s  an 
i n d i c a t i o n  o f  w h i c h  c o m b i n a t i o n  o f  a s s a y s  a r e  r e q u i r e d  t o  answer s p e c i f i c  
q u e s t i o n s .  W i t h  t h i s  t y p e  o f  i n f o r m a t i o n  i t  i s  p o s s i b l e  b y  c o m b i n a t i o n s  o f  
a s s a y s  w i t h  m a t h e m a t i c a l  a n a l y s i s  t o  p i n p o i n t  a s p e c i f i c  component  o f  t h e  
sys tem.  T h i s  p r o b l e m  can  somet imes  be s i m p l i f i e d  by f i r s t  a n a l y z i n g  t h e  
s a m p l e s  b y  SDSPAGE and i y m o g r a p h y  w i t h  t h e  s p e c i f i c  a n t i b o d i e s  t o  d e t e c t  t h e  
d i f f e r e n t  m o l e c u l a r  f o r m s  and d i f f e r e n t  m o l e c u l a r  s p e c i e s  p r e s e n t .  
I t  was d i s a p p o i n t i n g  t h a t  t h e  a s s a y s  f o r  human g r a n u l o c y t e  c o l o n y  
s t i m u l a t i n g  a c t i v i t y  were  n e g a t i v e  and t h a t  t h e  a 5 5 a y s  f o r  e r y t h r o p o e i t i n  
were  a t  b e s t  m a r g i n a l  i n  t h e  r e s p o n s e  t h a t  was o b t a i n e d . S i n c e  g r o u n d  b a s e d  
e x p e r i m e n t s  h a v e  shonn t h a t  e m b r y o n i c  k i d n e y  c e l l s  p r o d u c e  b o t h  o f  t h e s e  
b i o l o g i c a l  a c t i v i t i e s  when g r o n n  i n  c u l t u r e ,  t h e  l a c k  o f  d e t e c t a b l e  a c t i v i t y  
i n  t h e  space  e x p e r i m e n t s  must  b e  due t o  t h e  m e c h a n i c s  i n v o l v e d  i n  t h e  
t r e a t m e n t  o f  t h e  c e l l s  a n d / o r  c u l t u r e s .  
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1. FIBRIN PLATE LYSIS 
Diffusion based 
Not affected by many inhibitors 
Molecular weight dependent 
Zymogen partially seen 
2 .  MICRO CLOT LYSIS 
Modification of classic tube lysis method 
Measures uPA and tPA together all molecular weights 
Zymogen partially seen 
Inhibitors are functional 
3. CHROMOGENIC = DIRECT ASSAY WITH S-2444 
Sees both forms of uPA 
Zymogen not seen 
tPA most likely not seen 
Only activator inhibitors measured 
4 .  CHROMWENIC = ACTIVATED ASSAY WITH S-2444 
Sees all forms of uPA including zymogen 
tPA not seen 
Inhibitor same as S-2444 
5. PLASMINOGEN ACTIVATION MEASURE PLASMIN BY CER~OGKNIC WITH S2251 
Sees both forms UK 
Zymogen partially seen 
tPA not seen (modify by adding fibrin monomer) 
Sees inhibitor 
6. SDS PAGE WITH zy"y 
Shows all molecular weights for uPA-tPA 
Qualitative, not quantitative 
Does not differentiate zymogen 
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FIGURE 1. 
Plasminogen activator activity in conditioned medium from human kidney (HK) 
cell subpopulations as detected by amidolytic S-2444 (0) and fibrin plate 
lysis (A) assays. 
COMPARISON OF F/BR/N HATE AND CHRoYOoElwc ASSA YS 





Amidolytic activity detected after incubation of conditioned medium samples 
with plasmin for 30 minutes (activated, A) compared to activity of the same 
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FIGURE 3A. 
Comparison of the fibrin plate (t) and micro-clot lysis assays (0) for 
detecting fibrinolytic activity in conditioned medium form HK cell 
subpopulations. Both assays showed comparable activity except for the 
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FIGURE 3B. 
Presence of plasmin inhibitor in conditioned medium as detected by the 
chromogenic S-2251 0). Residual plasmin activity after addition of excess 
lys-plasmin to the samples is expressed as a percent of activity in 
unconditioned medium. 
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FIGURE 4. 
Plasminogen activators detected by a battery of five assays. These plots 
show the presence of active u-PA, (micro-clot lysis (+), S-2444 direct 01, 
and fibrin plate lysis (A) assays), scu-PA (difference between S2444 direct 
(0) and S-2444 activated (o), and total t-PA in ng/ml enzyme linked 
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FIGURE 5A. 
Fibrinogram from SDS PAGE gel on selected conditioned media samples from 
human embryonic kidney subpopulations. 
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FIGURE 5C. 
Fibrinogram from same SDS PAGE gel, 
activator antibody. 
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